Farrukh Iqbal

Farrukh Iqbal practices at SSM Health St. Mary's Hospital - St. Louis in Saint Louis, Missouri, part of SSM Health Care.

Farrukh Iqbal's NPI, 1023514999, was assigned on April 1, 2018. Farrukh Iqbal holds Missouri license 2021131988.

Farrukh Iqbal's primary practice is SSM Health St. Mary's Hospital - St. Louis, at 6420 Clayton Rd, Saint Louis, MO 63117 in St. Louis County. The practice phone is (314) 768-8000.

Farrukh Iqbal's primary practice is SSM Health St. Mary's Hospital - St. Louis in Saint Louis, Missouri, part of SSM Health Care. Farrukh Iqbal is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Farrukh Iqbal to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Farrukh Iqbal practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Farrukh Iqbal's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Farrukh Iqbal is board certified in internal medicine by the American Board of Internal Medicine. Farrukh Iqbal is licensed in Missouri.

CMS data shows 738 Medicare services from Farrukh Iqbal across 4 procedure codes in 2024, for 210 Medicare patients. Medicare paid $53,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Farrukh Iqbal in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Farrukh Iqbal's median patient age at 75, with 52% women.

In 2024, Farrukh Iqbal wrote 530 Medicare Part D claims for 225 patients. 87% of them were for generic drugs. CMS names the drug for 216 of them, across 13 drugs with 11 or more claims each, at $9,023 in total drug cost. In 2023, CMS named 174 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Farrukh Iqbal for performance year 2024, reported as part of a group. Farrukh Iqbal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Farrukh Iqbal from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $24.